Imported malaria in metropolitan France, from recommendations to clinical practice - proposal for improvement

A Dupré1, N Argy2, S Houze2

  • 1Service des maladies infectieuses et tropicales, hôpital Bichat-Claude-Bernard, groupe hospitalier universitaire AP-HP Nord, AP-HP, Paris, France.

Infectious Diseases Now
|August 31, 2021
PubMed
Abstract

Insights

This study reviewed imported malaria cases in Paris, finding challenges in adhering to national guidelines for diagnosis and patient management, particularly concerning initial workups and follow-up care for malaria patients.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Imported malaria is a significant concern in metropolitan France, with approximately 5000 cases annually.
  • National guidelines for malaria prevention and management were established by the French infectious disease society (SPILF) in 2017.

Purpose of the Study:

  • To retrospectively analyze imported malaria cases from 2015-2016 at a Parisian hospital.
  • To assess adherence to 2014 guidelines and identify areas for improvement in malaria case management.

Main Methods:

  • Retrospective analysis of 201 medical charts of imported malaria cases.
  • Evaluation of diagnostic procedures, clinical presentations, and treatment outcomes.

Main Results:

  • The majority of cases (97%) were acquired in sub-Saharan Africa, with Plasmodium falciparum being the predominant species (90%).
  • 26% of cases presented as severe malaria, with common symptoms including flu-like illness, fever, chills, and gastrointestinal issues.
  • A significant delay of 20 days was observed between return from endemic areas and diagnosis.

Conclusions:

  • Challenges were identified in achieving complete baseline biological workups for malaria patients.
  • Difficulties were noted in managing malaria patients with vomiting and in ensuring adequate post-treatment follow-up.
  • The study highlights the need for improved adherence to national guidelines for imported malaria.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...